CPHI Milan 2
CPHI Milan newsletter
PCI High Potent Manufacturing
LB Bohle – 10.06.2025
Temax_Krautz

Current Edition

Current Edition

Subsection - CDMO

Examining how innovative technologies, integrated manufacturing approaches and AI are shaping manufacturing.

Continue reading

Subsection - Injectables

Exploring advances in injectable drug delivery and sterile manufacturing, designed to improve patient-centric delivery.

Continue reading

Subsection - Neurodegenerative Diseases

Exploring emerging approaches to neurodegenerative disease research and treatment.

Continue reading

Subsection - Nasal & Pulmonary

Highlighting how advances in nasal and pulmonary drug delivery, formulation, devices and analytics are enabling more complex therapies.

Continue reading

Advertisement

CPHI 2027
DDL 2026

Advertisement

Nipro August 26

Advertisement

Merxin March 2026

Advertisement

Aurisco 300×250

Advertisement

Lifecore Biomedical
Volume 16 Issue 1

The Delivery of Pharmaceutical Drugs and How it Will Change the Future

Pharmaceutical drugs have seen a seismic shift over the past ten years, moving away from chemically synthesised drugs to focus more on a new class of biological drug...
Continue Reading →
Volume 16 Issue 1

Transforming the Biologics Product Lifecycle with Inhalation Innovation

In recent years, the biopharmaceuticals landscape has witnessed a revolutionary shift with the emergence of new nasal inhalation technologies. Among these, soft mist...
Continue Reading →
Volume 15 Issue 4

Auto-injectors: A Revolutionary Leap in Drug Delivery

In recent years, the biopharmaceutical industry has experienced a paradigm shift with the increasing prominence of auto-injectors. In 2023 the global auto[1]injector...
Continue Reading →
Volume 15 Issue 4

Drug Delivery Systems Making Inhaled Therapies Fit for the Future

Improving the Sustainability of Pressurised Metered Dose Inhalers Since their introduction in 1956, pressurised metered dose inhalers (pMDIs) have become the domi...
Continue Reading →
Volume 15 Issue 3

Chemical Recycled ABS Materials for the Transition to a Circular Economy Model

The demand for new, sustainable ABS materials for drug delivery device applications is growing in the healthcare sector. However, because of the risk of cross-contam...
Continue Reading →
Volume 15 Issue 2

Effective Operations for Risk Reduction and Supply Chain Resilience

There is no denying that the market for injectable drug delivery devices is growing rapidly, with forecasts predicting an increase from $39.93 billion in 2022 to $43...
Continue Reading →
Volume 15 Issue 1

Revolutionising Life Sciences Research and Delivery with a New Approach to Modelling Complexity

In life sciences, the adoption of new standards such as SDTM and ADaM is proving critical for efficient and effective data management and sharing. SDTM provides a ne...
Continue Reading →
Volume 15 Issue 1

Connected Drug Delivery Device Development: Where Are We At?

The market for parenteral drug-device combination products has evolved rapidly over the last 15–20 years and is expected to grow at a CAGR of 24.3% in the next eight...
Continue Reading →
Volume 14 issue 3

Handling with Care: Aseptic Dip Coating for Osteoporosis Treatment

Kindeva Drug Delivery is a contract development and manufacturing organisation (CDMO) specialising in complex drug formulation and delivery. Seeking to scale its pro...
Continue Reading →
News

Aptar Pharma to Unveil Inhalation Drug Delivery Solutions at CPhI China 2018

Aptar Pharma, a leading drug delivery systems provider, is pleased to be exhibiting once again at CPhI China 2018, taking place from June 20-22 at the Shanghai ...
Continue Reading →

Advertisement

MedPharm 16/07

Advertisement

Biopharma group march 2026

Advertisement

Silgan March 2026

Advertisement

Terumo 06/26

Advertisement

Scott Pharma – 25.03.2025

Advertisement

Bespak

Advertisement

Solstice

Advertisement

Bachem skyscraper
Tjoapack
Aptar – 08/01/2026